Hunan Hansen Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio
Hunan Hansen Pharmaceutical Co Ltd cash flow-to-debt ratio. Hunan Hansen Pharmaceutical Co Ltd (002412) has a Cash Flow-to-Debt Ratio of 0.17x as of September 2025, meaning its operating cash flow of CN¥52.51 Million could theoretically repay 0% of its total liabilities (CN¥301.66 Million) in one year. Check 002412 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Hunan Hansen Pharmaceutical Co Ltd (2007–2025)
Cash flow-to-debt ratio of Hunan Hansen Pharmaceutical Co Ltd from 2007 to 2025. Historical debt coverage capacity for Hunan Hansen Pharmaceutical Co Ltd across 19 annual periods. Check Hunan Hansen Pharmaceutical Co Ltd (002412) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Hunan Hansen Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio by Year (2007–2025)
Hunan Hansen Pharmaceutical Co Ltd cash flow-to-debt ratio by year from 2007 to 2025. Year-by-year debt coverage analysis for Hunan Hansen Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 002412 operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.79x | CN¥245.38 Million | CN¥312.15 Million | ▲ +106.7% |
| 2024 | 0.38x | CN¥130.78 Million | CN¥343.85 Million | ▼ -11.7% |
| 2023 | 0.43x | CN¥160.95 Million | CN¥373.46 Million | ▲ +18.9% |
| 2022 | 0.36x | CN¥143.81 Million | CN¥396.81 Million | ▼ -37.1% |
| 2021 | 0.58x | CN¥212.54 Million | CN¥368.99 Million | ▲ +4.4% |
| 2020 | 0.55x | CN¥162.19 Million | CN¥293.92 Million | ▲ +18.0% |
| 2019 | 0.47x | CN¥165.11 Million | CN¥352.93 Million | ▼ -6.4% |
| 2018 | 0.50x | CN¥217.52 Million | CN¥435.02 Million | ▲ +124.5% |
| 2017 | 0.22x | CN¥107.18 Million | CN¥481.18 Million | ▼ -42.5% |
| 2016 | 0.39x | CN¥161.16 Million | CN¥415.88 Million | ▼ -22.7% |
| 2015 | 0.50x | CN¥63.57 Million | CN¥126.83 Million | ▲ +26.5% |
| 2014 | 0.40x | CN¥85.05 Million | CN¥214.59 Million | ▲ +11.7% |
| 2013 | 0.35x | CN¥76.09 Million | CN¥214.46 Million | ▼ -72.8% |
| 2012 | 1.31x | CN¥100.23 Million | CN¥76.76 Million | ▲ +33.3% |
| 2011 | 0.98x | CN¥53.84 Million | CN¥54.95 Million | ▲ +127.1% |
| 2010 | 0.43x | CN¥21.24 Million | CN¥49.23 Million | ▼ -28.8% |
| 2009 | 0.61x | CN¥41.02 Million | CN¥67.69 Million | ▲ +51.2% |
| 2008 | 0.40x | CN¥33.94 Million | CN¥84.67 Million | ▼ -8.2% |
| 2007 | 0.44x | CN¥37.75 Million | CN¥86.49 Million | — |